Curley Joanne
SEC CIK 1857670 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Chief Development Off | 27.0K | — | $1.82M | 31 | 2022-05-31 | 2023-08-21 |
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
Curley Joanne made no open-market trades at VERA in the last 12 months.
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-23 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale | $16.66 | -1,490 | 27.0K | -5% | -$24.8K | |
| DM | 2022-12-19 | 2022-12-16 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $2.90 | +2,212 | 27.6K | +9% | +$6,415 |
| DM | 2022-12-19 | 2022-12-16 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $19.49 | -2,212 | 26.8K | -8% | -$43.1K |
| DM | 2022-12-14 | 2022-12-12+ | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $10.75 | +19.7K | 27.9K | +241% | +$211.8K |
| DM | 2022-12-14 | 2022-12-12+ | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $18.26 | -19.7K | 26.8K | -42% | -$360.0K |
| 2022-12-08 | 2022-12-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale | $16.47 | -494 | 26.8K | -2% | -$8,136 | |
| DM | 2022-11-21 | 2022-11-17 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $15.85 | -3,289 | 27.3K | -11% | -$52.1K |
| DM | 2022-11-21 | 2022-11-17 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $4.04 | +3,289 | 28.4K | +13% | +$13.3K |
| 2022-11-10 | 2022-11-09 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale | $16.54 | -494 | 27.3K | -2% | -$8,171 | |
| DM | 2022-10-20 | 2022-10-18 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $8.33 | +8,590 | 33.1K | +35% | +$71.6K |
| DM | 2022-10-20 | 2022-10-18 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $19.41 | -8,590 | 27.8K | -24% | -$166.8K |
| 2022-10-06 | 2022-10-05 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale | $21.64 | -988 | 27.8K | -3% | -$21.4K | |
| DM | 2022-09-22 | 2022-09-20+ | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $20.72 | -16.8K | 28.8K | -37% | -$348.9K |
| DM | 2022-09-22 | 2022-09-20+ | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $9.66 | +16.8K | 38.9K | +76% | +$162.7K |
| 2022-09-08 | 2022-09-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale | $18.63 | -988 | 28.8K | -3% | -$18.4K | |
| D | 2022-08-23 | 2022-08-19 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | A - Grant | $0.00 | +12.5K | 29.8K | +72% | $0 |
| DM | 2022-08-23 | 2022-08-19+ | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $8.37 | +8,539 | 30.4K | +39% | +$71.4K |
| DM | 2022-08-23 | 2022-08-19+ | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $19.13 | -8,539 | 29.8K | -22% | -$163.4K |
| 2022-08-04 | 2022-08-03 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale | $16.81 | -988 | 17.3K | -5% | -$16.6K | |
| DM | 2022-07-20 | 2022-07-19 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $4.53 | +11.4K | 18.3K | +167% | +$51.9K |
| DM | 2022-07-20 | 2022-07-19 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $16.02 | -11.4K | 18.3K | -39% | -$183.3K |
| DM | 2022-07-15 | 2022-07-14 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $15.14 | -9,104 | 21.0K | -30% | -$137.9K |
| D | 2022-07-15 | 2022-07-14 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $2.90 | +6,354 | 27.4K | +30% | +$18.4K |
| DM | 2022-07-11 | 2022-07-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $15.05 | -9,666 | 23.7K | -29% | -$145.5K |
| DM | 2022-07-11 | 2022-07-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $4.63 | +7,001 | 27.2K | +35% | +$32.4K |
| DM | 2022-06-23 | 2022-06-22 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $15.01 | -1,545 | 24.0K | -6% | -$23.2K |
| D | 2022-06-23 | 2022-06-22 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $6.37 | +1,239 | 25.2K | +5% | +$7,892 |
| DM | 2022-06-21 | 2022-06-17 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $3.90 | +4,687 | 28.5K | +20% | +$18.3K |
| DM | 2022-06-21 | 2022-06-17 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $15.05 | -5,887 | 24.0K | -20% | -$88.6K |
| D | 2022-06-02 | 2022-05-31 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | S - Sale+OE | $15.22 | -400 | 25.2K | -2% | -$6,088 |
| D | 2022-06-02 | 2022-05-31 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Chief Development Off | M - OptEx | $6.37 | +400 | 25.6K | +2% | +$2,548 |
Purchase Sale Sale after option exercise All abbreviations